{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:45:33Z","timestamp":1757619933644,"version":"3.44.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Grupo SURA"},{"name":"GRUPO ISA"},{"name":"Gobernacion de Antioquia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05431-8","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T14:27:12Z","timestamp":1753626432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Critical illness in immunocompromised patients: insights into relapse or persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): case series report"],"prefix":"10.1186","volume":"19","author":[{"given":"Olga H.","family":"Hern\u00e1ndez-Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Felipe","family":"Llano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Milena","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Melissa","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura S.","family":"Perez-Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Usuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0404-9947","authenticated-orcid":false,"given":"Juan Pablo","family":"Hern\u00e1ndez-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,27]]},"reference":[{"issue":"23","key":"5431_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1056\/NEJMoa2105000","volume":"384","author":"E Hacisuleyman","year":"2021","unstructured":"Hacisuleyman E, Hale C, Saito Y, Blachere NE, Bergh M, Conlon EG, et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med. 2021;384(23):2212\u20138.","journal-title":"N Engl J Med"},{"issue":"24","key":"5431_CR2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114228","volume":"385","author":"Y Goldberg","year":"2021","unstructured":"Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Haas EJ, et al. Waning immunity after the BNT162b2 vaccine in Israel. N Engl J Med. 2021;385(24): e85.","journal-title":"N Engl J Med"},{"issue":"23","key":"5431_CR3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","volume":"386","author":"Y Goldberg","year":"2022","unstructured":"Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman LS, Ash N, et al. Protection and waning of natural and hybrid immunity to SARS-CoV-2. N Engl J Med. 2022;386(23):2201\u201312.","journal-title":"N Engl J Med"},{"issue":"6485","key":"5431_CR4","first-page":"1444","volume":"367","author":"R Yan","year":"2020","unstructured":"Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (1979). 2020;367(6485):1444\u20138.","journal-title":"Science (1979)"},{"issue":"2","key":"5431_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281-292.e6.","journal-title":"Cell"},{"issue":"7819","key":"5431_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41586-020-2380-z","volume":"584","author":"B Ju","year":"2020","unstructured":"Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, et al. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Nature. 2020;584(7819):115\u20139.","journal-title":"Nature"},{"key":"5431_CR7","doi-asserted-by":"publisher","first-page":"917905","DOI":"10.3389\/fimmu.2022.917905","volume":"13","author":"T Adjobimey","year":"2022","unstructured":"Adjobimey T, Meyer J, Sollberg L, Bawolt M, Berens C, Kova\u010devi\u0107 P, et al. Comparison of IgA, IgG, and neutralizing antibody responses following immunization with moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm\u2019s COVID-19 vaccines. Front Immunol. 2022;13:917905.","journal-title":"Front Immunol"},{"issue":"12","key":"5431_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","volume":"22","author":"K Tao","year":"2021","unstructured":"Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22(12):757\u201373.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"5431_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12016-021-08908-8","volume":"64","author":"R Qin","year":"2023","unstructured":"Qin R, He L, Yang Z, Jia N, Chen R, Xie J, et al. Identification of parameters representative of immune dysfunction in patients with severe and fatal COVID-19 infection: a systematic review and meta-analysis. Clin Rev Allergy Immunol. 2023;64(1):33\u201365.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"5431_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jinf.2021.01.022","volume":"82","author":"JA Belsky","year":"2021","unstructured":"Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect. 2021;82(3):329.","journal-title":"J Infect"},{"issue":"12","key":"5431_CR11","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s00296-020-04699-x","volume":"40","author":"J Loarce-Martos","year":"2020","unstructured":"Loarce-Martos J, Garc\u00eda-Fern\u00e1ndez A, L\u00f3pez-Guti\u00e9rrez F, Garc\u00eda-Garc\u00eda V, Calvo-Sanz L, del Bosque-Granero I, et al. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study. Rheumatol Int. 2020;40(12):2015.","journal-title":"Rheumatol Int"},{"issue":"5","key":"5431_CR12","doi-asserted-by":"publisher","first-page":"2051412","DOI":"10.1080\/21645515.2022.2051412","volume":"18","author":"Z Mohseni Afshar","year":"2022","unstructured":"Mohseni Afshar Z, Barary M, Hosseinzadeh R, Alijanpour A, Hosseinzadeh D, Ebrahimpour S, et al. Breakthrough SARS-CoV-2 infections after vaccination: a critical review. Hum Vaccin Immunother. 2022;18(5):2051412.","journal-title":"Hum Vaccin Immunother"},{"key":"5431_CR13","doi-asserted-by":"publisher","first-page":"112911","DOI":"10.1016\/j.envres.2022.112911","volume":"209","author":"S Pilz","year":"2022","unstructured":"Pilz S, Theiler-Schwetz V, Trummer C, Krause R, Ioannidis JPA. SARS-CoV-2 reinfections: overview of efficacy and duration of natural and hybrid immunity. Environ Res. 2022;209:112911.","journal-title":"Environ Res"},{"issue":"7","key":"5431_CR14","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.18632\/aging.103000","volume":"12","author":"B Wang","year":"2020","unstructured":"Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging. 2020;12(7):6049\u201357.","journal-title":"Aging"},{"issue":"1","key":"5431_CR15","doi-asserted-by":"publisher","first-page":"100588","DOI":"10.1016\/j.trre.2020.100588","volume":"35","author":"MA Raja","year":"2021","unstructured":"Raja MA, Mendoza MA, Villavicencio A, Anjan S, Reynolds JM, Kittipibul V, et al. COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature. Transplant Rev. 2021;35(1):100588.","journal-title":"Transplant Rev"},{"issue":"6","key":"5431_CR16","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1007\/s10787-023-01349-z","volume":"31","author":"CS Kow","year":"2023","unstructured":"Kow CS, Ramachandram DS, Hasan SS, Thiruchelvam K. Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes. Inflammopharmacology. 2023;31(6):3339\u201355.","journal-title":"Inflammopharmacology"},{"key":"5431_CR17","doi-asserted-by":"publisher","DOI":"10.1017\/S095026882000179X","volume":"148","author":"M Ou","year":"2020","unstructured":"Ou M, Zhu J, Ji P, Li H, Zhong Z, Li B, et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect. 2020;148: e175.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"5431_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/22221751.2021.1884503","volume":"10","author":"X Yongzhi","year":"2021","unstructured":"Yongzhi X. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new issue. Emerg Microbes Infect. 2021;10(1):266\u201376.","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"5431_CR19","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00262-020-02822-2","volume":"70","author":"N Panoskaltsis","year":"2021","unstructured":"Panoskaltsis N. Are all cytokine storms the same? Cancer Immunol Immunother. 2021;70(4):887\u201392.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"5431_CR20","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.3390\/ijerph20043335","volume":"20","author":"J Deng","year":"2023","unstructured":"Deng J, Ma Y, Liu Q, Du M, Liu M, Liu J. Severity and outcomes of SARS-CoV-2 reinfection compared with primary infection: a systematic review and meta-analysis. Int J Environ Res Public Health. 2023;20(4):3335.","journal-title":"Int J Environ Res Public Health"},{"issue":"10379","key":"5431_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0140-6736(22)02465-5","volume":"401","author":"C Stein","year":"2023","unstructured":"Stein C, Nassereldine H, Sorensen RJD, Amlag JO, Bisignano C, Byrne S, et al. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Lancet. 2023;401(10379):833\u201342.","journal-title":"Lancet"},{"issue":"3","key":"5431_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cmi.2020.11.028","volume":"27","author":"D Yahav","year":"2021","unstructured":"Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, et al. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021;27(3):315.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"5431_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.reuma.2020.03.001","volume":"17","author":"O Sanchez-Pernaute","year":"2021","unstructured":"Sanchez-Pernaute O, Romero-Bueno FI, Selva-O\u2019Callaghan A. Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia. Reumatol Clin. 2021;17(9):556\u20137.","journal-title":"Reumatol Clin"},{"issue":"13","key":"5431_CR24","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2020.17023","volume":"324","author":"JAC Sterne","year":"2020","unstructured":"Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC, et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA. 2020;324(13):1330\u201341.","journal-title":"JAMA"},{"key":"5431_CR25","doi-asserted-by":"publisher","first-page":"763412","DOI":"10.3389\/fimmu.2021.763412","volume":"12","author":"A Furlan","year":"2021","unstructured":"Furlan A, Forner G, Cipriani L, Vian E, Rigoli R, Gherlinzoni F, et al. COVID-19 in B cell-depleted patients after rituximab: a diagnostic and therapeutic challenge. Front Immunol. 2021;12:763412.","journal-title":"Front Immunol"},{"issue":"6","key":"5431_CR26","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1182\/blood.V100.6.2257","volume":"100","author":"LE Van Der Kolk","year":"2002","unstructured":"Van Der Kolk LE, Baars JW, Prins MH, Van Oers MHJ. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood. 2002;100(6):2257\u20139.","journal-title":"Blood"},{"issue":"6","key":"5431_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1017\/ice.2020.1273","volume":"42","author":"F Lm","year":"2021","unstructured":"Lm F, Ah V, Mk S, Jc M. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): review of current literature. Infect Control Hosp Epidemiol. 2021;42(6):659\u201368.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"23","key":"5431_CR28","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMc2031364","volume":"383","author":"B Choi","year":"2020","unstructured":"Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020;383(23):2291\u20133.","journal-title":"N Engl J Med"},{"issue":"1","key":"5431_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","volume":"223","author":"JH Baang","year":"2021","unstructured":"Baang JH, Smith C, Mirabelli C, Valesano AL, Manthei DM, Bachman MA, et al. Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient. J Infect Dis. 2021;223(1):23\u20137.","journal-title":"J Infect Dis"},{"key":"5431_CR30","unstructured":"Centers for Disease Control and Prevention. People with certain medical conditions [Internet]. Atlanta, GA: CDC; 2023 [cited 2025 Jul\n24]. Available from: https:\/\/www.cdc.gov\/covid\/risk-factors\/index.html"},{"issue":"12","key":"5431_CR31","first-page":"CD015477","volume":"12","author":"C Gra\u00f1a","year":"2022","unstructured":"Gra\u00f1a C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, et al. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022;12(12):CD015477.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5431_CR32","first-page":"CD013881","volume":"3","author":"L Ghosn","year":"2021","unstructured":"Ghosn L, Chaimani A, Evrenoglou T, Davidson M, Gra\u00f1a C, Schmucker C, et al. Interleukin-6 blocking agents for treating COVID-19: a living systematic review. Cochrane Database Syst Rev. 2021;3(3):CD013881.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"5431_CR33","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"5431_CR34","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28568","volume":"4","author":"D Groff","year":"2021","unstructured":"Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4(10): e2128568.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"5431_CR35","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u201346.","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"5431_CR36","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/infdis\/jiab490","volume":"224","author":"MJ Peluso","year":"2021","unstructured":"Peluso MJ, Lu S, Tang AF, Durstenfeld MS, Ho HE, Goldberg SA, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224(11):1839\u201348.","journal-title":"J Infect Dis"},{"key":"5431_CR37","doi-asserted-by":"publisher","first-page":"1011936","DOI":"10.3389\/fmed.2023.1011936","volume":"10","author":"RN Low","year":"2023","unstructured":"Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of long COVID symptoms. Front Med. 2023;10:1011936.","journal-title":"Front Med"},{"issue":"1","key":"5431_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jiph.2022.11.024","volume":"16","author":"K Dhama","year":"2023","unstructured":"Dhama K, Nainu F, Frediansyah A, Yatoo MI, Mohapatra RK, Chakraborty S, et al. Global emerging Omicron variant of SARS-CoV-2: impacts, challenges and strategies. J Infect Public Health. 2023;16(1):4\u201314.","journal-title":"J Infect Public Health"},{"issue":"3","key":"5431_CR39","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s40121-021-00458-y","volume":"10","author":"F Zheng","year":"2021","unstructured":"Zheng F, Chen R, Yao R, Huang Y, Tan X, Liu J, et al. Dynamic changes in the immune response correlate with disease severity and outcomes during infection with SARS-CoV-2. Infect Dis Ther. 2021;10(3):1391\u2013405.","journal-title":"Infect Dis Ther"},{"issue":"7898","key":"5431_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","volume":"602","author":"Y Cao","year":"2022","unstructured":"Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657\u201363.","journal-title":"Nature"},{"issue":"10","key":"5431_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1136\/annrheumdis-2021-220781","volume":"80","author":"D Mrak","year":"2021","unstructured":"Mrak D, Tobudic S, Koblischke M, Graninger M, Radner H, Sieghart D, et al. SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity. Ann Rheum Dis. 2021;80(10):1345\u201350.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"5431_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273612","volume":"17","author":"M Wasserbauer","year":"2022","unstructured":"Wasserbauer M, Hlava S, Trojanek M, Stovicek J, Milota T, Drabek J, et al. Efficacy and safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive and biological therapy: prospective observational study. PLoS ONE. 2022;17(9): e0273612.","journal-title":"PLoS ONE"},{"issue":"1","key":"5431_CR43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/imr.13089","volume":"310","author":"A Sette","year":"2022","unstructured":"Sette A, Crotty S. Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines. Immunol Rev. 2022;310(1):27\u201346.","journal-title":"Immunol Rev"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05431-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05431-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05431-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:49:31Z","timestamp":1757306971000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05431-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5431"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05431-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2025,7,27]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We have followed the procedures in accordance with the Helsinki Declaration. The patients or their legal representatives provided informed consent to participate in the study titled \u201cImmune response against SARS-CoV-2 and its association with mortality, organ dysfunction, and post-COVID syndrome; characterization of immunity status; and genomic surveillance of viral variants.\u201d This study involves a cohort of patients who were hospitalized in the metropolitan area of the Aburr\u00e1 Valley, Medell\u00edn, Colombia, between 2021 and 2023. The authors confirm that the manuscript followed the Case Report (CARE) Checklist regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"371"}}